GE HealthCare Technologies Inc. (GEHC) earnings on July 29, 2026
More GE HealthCare Technologies Inc. earnings
Prior outlook: Optimistic Outcome: Accurate
GE HealthCare shares surged 12% after the company reported a record backlog of orders.
GEHC price around the earnings
71.90
Change: +12.2%
2026-07-29, 20:00 UTC
Start of the measured window
End of the measured window
64.11
67.07
70.04
73.00
64.11
July 29, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- Starting price
Prior thesis
Prior outlook: Optimistic Outcome: Accurate
- Thesis published
- Results released
Analyst upside strong (+23.7%) and Q2 revenue +5.7%, but negative q_earnings and EPS miss create headwinds.
Context analyzed before publication
- Trend
- Trajectory shows a clear upward trend and significant run-up into earnings, suggesting high expectations.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.74
- Analysts covering the stock
- 18
- Average price target
- 79.33
- Lowest price target
- 65
- Highest price target
- 98
- Upside to price target
- 23.7%
- Quarterly earnings growth
- -31%
- Revenue growth
- 7.4%
- Forward EPS
- 5.36
- Trailing EPS
- 4.37
- Analyst moves in the last 60 days
- 4
- Strong buy: 4
- Buy: 10
- Hold: 5
- Sell: 0
- Strong sell: 0
- Strong buy
- 4
- Buy
- 10
- Hold
- 5
- Sell
- 0
- Strong sell
- 0
- July 17, 2026 · Hovde Group: Initiates coverage (Market Perform)
- July 16, 2026 · UBS: Maintains rating (Neutral → Neutral)
- July 9, 2026 · BMO Capital: Initiates coverage (Market Perform)
- June 23, 2026 · RBC Capital: Initiates coverage (Outperform)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (5)
- GE HealthCare Appoints Chief Accounting Officer George Newcomb Interim CFO, Succeeding Jay Saccaro; Co. Anticipates Reporting 5.7% Revenue Growth For Q2, Reiterates FY26 Outlook (opens in a new tab) — Benzinga
- UBS Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $67 (opens in a new tab) — Benzinga
- Catholic Health And GE HealthCare Announce $500M, 10-Year Care Alliance To Expand Patient Access Across Long Island (opens in a new tab) — Benzinga
- BMO Capital Initiates Coverage On GE HealthCare Techs with Market Perform Rating, Announces Price Target of $70 (opens in a new tab) — Benzinga
- GE HealthCare And Mayo Clinic Announce MI-BET Research Collaboration, Theranostics Study To Explore Personalized Approach To Radioligand Therapy For Advanced Prostate Cancer Patients (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 64.17
- Average true range (ATR)
- 3.2%
- Distance to 52-week high
- -30.6%
- 14-day change (14d)
- +4.0%
- 30-day change (32d)
- -2.3%
- 30-day relative strength
- +2.0%
- QQQ change (32d)
- -4.3%
- Nearest support
- 63.76
- Distance to nearest support
- 0.6%
- Nearest resistance
- 64.35
- Distance to nearest resistance
- 0.3%
- Volume accumulation ratio (14d / 46d)
- 1.1
- Mid: 63.76 (0.6% away, 0.19 ATR, 25 touches)
- Mid: 63.42 (1.2% away, 0.36 ATR, 17 touches)
- Mid: 63.07 (1.7% away, 0.53 ATR, 23 touches)
- Major: 64.35 (0.3% away, 0.09 ATR, 20 touches)
- Major: 64.69 (0.8% away, 0.25 ATR, 30 touches)
- Major: 65.03 (1.3% away, 0.41 ATR, 38 touches)
Trends
Evidence
- Average earnings surprise
- +3.8%
- April 29, 2026: actual EPS 0.99 vs estimate 1.05 (surprise -5.7%)
- February 4, 2026: actual EPS 1.44 vs estimate 1.4 (surprise +3.0%)
- October 29, 2025: actual EPS 1.07 vs estimate 1.05 (surprise +2.2%)
- July 30, 2025: actual EPS 1.06 vs estimate 0.92 (surprise +15.5%)
Expected move
- Implied move
- +7.4%
- Source
- Options chain
Reactions over its last 14 earnings
- Median move
- 5.2%
- 75th percentile move
- 8.7%
- 90th percentile move
- 12.7%
- Up / down moves
- 8 / 6
- Average up move
- +5.1%
- Average down move
- -7.8%
Monitoring and close
What GE HealthCare Technologies Inc. reported
- Status
- Finished
| Actual EPS | 1.13 |
|---|---|
| EPS estimate | 1.03 |
| EPS surprise | +9.7% |
| Revenue | $5,295 million |
| Revenue estimate | $5,264 million |
| Revenue surprise | +0.6% |
GE HealthCare continues to navigate broader market declines as the Dow fell 1,110 points amid Fed rate concerns, while maintaining its strong orders growth and record backlog.
Sources (27)
- GE HealthCare Technologies Inc (GEHC) Q2 2026 Earnings Call Highlights: Strong Orders Growth ... (opens in a new tab) — GuruFocus.com
- BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $79 (opens in a new tab) — Benzinga
- GE HealthCare Technologies Inc. Q2 2026 Earnings Call Summary (opens in a new tab) — Moby
- Tech, Media & Telecom Roundup: Market Talk (opens in a new tab) — The Wall Street Journal
- Here's Why GE Healthcare Shares Popped Higher Today (opens in a new tab) — Motley Fool
- GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market (opens in a new tab) — Zacks
- GE HealthCare Hits Record Backlog, Stock Jumps (opens in a new tab) — Benzinga
- GE HealthCare Says Increased Orders, Healthy Demand Lifted Revenue (opens in a new tab) — The Wall Street Journal
- Stock Market Today: Dow Dives 800 Points As Fed Rate Call Looms; GE HealthCare Soars (Live Coverage) (opens in a new tab) — Investor's Business Daily
- Vertiv, SoFi, GE HealthCare, Micron, SK Hynix, Garmin, and More Stocks That Explain Today’s Market (opens in a new tab) — Barrons.com
- S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings (opens in a new tab) — Investor's Business Daily
- GE HealthCare Technologies Q2 Earnings Call Highlights (opens in a new tab) — MarketBeat
- GE HealthCare Stock Soars After Earnings—and It’s Suddenly the Best Performing GE (opens in a new tab) — Barrons.com
- Ford, Garmin, GE HealthCare, Clean Harbors And Other Big Stocks Moving Higher On Wednesday (opens in a new tab) — Benzinga
- Vertiv, SK Hynix, SoFi, Bloom Energy, GE HealthCare, and More Stocks That Explain Today’s Market (opens in a new tab) — Barrons.com
- GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript (opens in a new tab) — SeekingAlpha
- GE HealthCare Beats Second-Quarter Expectations as Record Orders Drive Growth (opens in a new tab) — InvestorsHub
- GE HealthCare Technologies (GEHC) Beats Q2 Earnings and Revenue Estimates (opens in a new tab) — Zacks
- GE HealthCare Stock Soars After Earnings. Here’s What Drove the Profit Gains. (opens in a new tab) — Barrons.com
- GE HealthCare (NASDAQ:GEHC) Surges on Q2 Earnings Beat (opens in a new tab) — ChartMill
- GE HealthCare beats estimates as orders surge to record high (opens in a new tab) — Investing.com
- GE HealthCare Posts Higher Profit, Revenue on Increased Orders (opens in a new tab) — The Wall Street Journal
- GE HealthCare’s (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars (opens in a new tab) — StockStory
- GE HealthCare Techs Affirms FY2026 Adj EPS Guidance of $4.80-$5.00 vs $4.87 Est (opens in a new tab) — Benzinga
- GE HealthCare beat Q2 expectations with adjusted EPS of $1.13 and revenue of $5.295 billion. — Benzinga
- GE HealthCare Techs Q2 Adj. EPS $1.13 Beats $1.03 Estimate, Sales $5.295B Beat $5.264B Estimate (opens in a new tab) — Benzinga
- GE HealthCare reports second quarter 2026 financial results (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, the figures confirm the optimistic scenario. In the 1038 past cases with a similar move, the close held that direction 96% of the time.
How the stock reacted
- Outcome
- Accurate
- Consolidated
- +12.2%
- Max favorable move (MFE)
- 13.9%
- Max adverse move (MAE)
- 0%